Accelerated-phase Chronic Myeloid Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-02-17
Clinical Trial Update: Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of ipilimumab and dasatinib in patients with chronic or accelerated chronic myeloid leukemia has …